Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
India flag India · Delayed Price · Currency is INR
1,190.75
+30.25 (2.61%)
Oct 8, 2024, 3:29 PM IST

Suven Pharmaceuticals Revenue

Suven Pharmaceuticals had revenue of 2.31B INR in the quarter ending June 30, 2024, a decrease of -33.62%. This brings the company's revenue in the last twelve months to 9.34B, down -30.73% year-over-year. In the fiscal year ending March 31, 2024, Suven Pharmaceuticals had annual revenue of 10.51B, down -21.56%.

Revenue (ttm)
9.34B
Revenue Growth
-30.73%
P/S Ratio
32.42
Revenue / Employee
7.83M
Employees
1,193
Market Cap
303.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202410.51B-2.89B-21.56%
Mar 31, 202313.40B201.07M1.52%
Mar 31, 202213.20B3.11B30.75%
Mar 31, 202110.10B1.76B21.10%
Mar 31, 20208.34B-730.13M-8.05%
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition